Sep 2026· Journal of King Saud University: Science· 0 citations· 38 references
TL;DR
Allicin acts as a pro-oxidant, regulating programmed cell death pathways in BT-549 cancer cells through ROS signaling, and the involvement of reactive oxygen species in regulating these signaling pathways is indicated.
Abstract
Breast cancer continues to represent a major contributor to cancer-related mortality, creating a severe public health burden worldwide. Adjuvant therapy is essential for nearly fifty percent of breast cancer patients following surgery to mitigate recurrence. Consequently, the use of effective chemotherapeutic agents to suppress tumor progression is a viable strategy for the management of breast cancer patients. Therefore, this study investigates the effects of allicin, a natural compound derived from garlic, on BT-549 human breast cancer cells. Additionally, its molecular mechanisms in programmed cell death were evaluated using a series of biochemical and cellular assays. The results demonstrated that allicin induces caspase-dependent cell death in cancer cells and enhances apoptotic signaling, as seen by elevated caspase expression. Furthermore, allicin induces the expression of protein markers associated with endoplasmic reticulum (ER) stress and activates c-Jun NH2-terminal kinase (JNK), which correlates with increased levels of proapoptotic markers. These findings indicate the involvement of reactive oxygen species in regulating these signaling pathways. Moreover, treatment with a JNK-specific inhibitor (SP600125) markedly reduced the effects of allicin and inhibited apoptotic marker expression in BT-549 cancer cells. Our preliminary findings suggest that allicin acts as a pro-oxidant, regulating programmed cell death pathways in BT-549 cancer cells through ROS signaling.
Background: Breast cancer is the most common malignancy and the leading cause of cancer-related death for women globally. There is currently no tumor-specific targeted therapy for TNBC, in contrast to other clinical subtypes of breast cancer. Nervonic acid (NA), a very long-chain omega-9 fatty acid, has been reported t...
Manisha Phoujdar, Ananya Dutta, S. Raut et al.· BioMed· 0 citations
Background: Non-small-cell lung cancer (NSCLC) is a major cause of cancer-related mortality. Current therapies are limited by drug resistance and adverse effects, highlighting the need for new strategies. Panduratin A (PA), a chalcone from Boesenbergia rotunda, has reported anticancer activity. This study investigated...
Findings identify heat-labile, NET-associated components as mediators of breast cancer chemoresistance and support targeting NETs or their downstream signaling pathways to improve chemotherapy response.
J. L. Souza, V. Almeida, K. Martins-Cardoso et al.· Frontiers in Immunology· 0 citations
Lung cancer remains a major cause of death globally, responsible for a significant portion of all cancer-related deaths despite advancements in therapeutic modalities. Consequently, there is a great demand for new treatment strategies that can improve anti-cancer efficiency while minimizing toxicity
in vivo
....
Collectively, emodin suppresses CRCSC characteristics in vitro by downregulating Wnt/β-catenin signaling and inducing AIF-associated caspase-independent apoptosis, highlighting its therapeutic potential against CRC.
M. Ahmadi, Hong Lae Kim, H. Jung· Biomolecules & Therapeutics· 0 citations
Colorectal cancer (CRC) is the third most prevalent cancer globally, with limited effective treatment options and significant chemotherapy resistance. Saikosaponin A (SSA), a triterpenoid saponin from Radix Bupleuri, exhibits anti-inflammatory and antitumor properties, but its mechanism of action in CRC remains und...
Xiu-Xiu Zhang, Jing-Ling Yang, Wang-Wei Zhang et al.· Food Science and Human Welln...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.